Additionally, Pakravan et al. revealed that the transfer of miR-100 from human BM-MSC-derived exosomes to breast cancer cells decreased VEGF expression and secretion by modulating the mTOR/HIF-1/VEGF signaling axis [173]. This evidence concerns the gene VEGFA and breast carcinoma.